期刊文献+

维持性血液透析患者低甲状旁腺激素血症的影响因素研究 被引量:2

Clinical study of low hypothyroid hormone in patients with maintenance hemodialysis
下载PDF
导出
摘要 目的探讨维持性血液透析(MHD)患者低甲状旁腺激素血症的影响因素。方法选择MHD患者179例,按透析前的血浆全段甲状旁腺激素(iPTH)水平分为2组:A组(低甲状旁腺激素血症组)患者血清iPTH<150 pg/m;B组患者血清iPTH≥150 pg/mL。结果 179例MHD患者血iPTH平均浓度为(229.62±139.92)pg/mL,iPTH达标者83例(46.37%),低甲状旁腺激素血症63例(35.2%),高于标准者33例(18.43%)。A组患者与B组患者相比较,A组患者的年龄大、糖尿病发生率高、血清钙水平高,血清磷水平、血浆白蛋白水平低,其差异有统计学意义(P<0.05)。而2组患者在性别构成、透析龄、平均动脉压、血红蛋白、尿素氮、肌酐、服用钙剂、服用活性维生素D制剂等方面比较差异无统计学意义(P>0.05)。Pearson相关分析结果显示,MHD患者发生低甲状旁腺激素血症与患者年龄、患有糖尿病、血浆白蛋白水平、血清钙水平、血清磷水平等因素有相关性(P<0.05);Logistic回归分析结果显示,MHD患者的年龄和血清磷水平是发生低甲状旁腺激素血症的独立危险因素(P<0.05)。结论 MHD患者易发生低甲状旁腺激素血症,年龄和血清磷水平是MHD患者发生低甲状旁腺激素血症的独立危险因素。 Objective To investigate the influencing factors of hypothyroid hormone in patients with maintenance hemodialysis (MHD). Methods According to the level of intact parathyroid hormone (iPTH)before dialysis, the patients 179 patients with MHD were divided into two groups:Group A,serum iPTH 〈 150 pg/mL(low serum iPTH group) ;group B,the serum iPTH acuity 〉 150 pg,/mL. Results The average concentration blood iPTH of 179 cases of MHD patients was (229.62 ± 139.92) pg/ml, iPTH compliance was 83 cases (46.37%),low parathyroid hormone was 63 cases (35.2%), the patients who were higher than the standard were 33 cases ( 18.43 % ). Compared with group B, the age of group A was older, the incidence of diabetes was higher, the concentration of serum calci- um was higher, and the levels of serum phosphorus and plasma albumin were lower. The difference was statistically significant. There was no significant difference in gender composition, dialysis age, mean arterial pressure, urea, creatinine, hemoglobin, taking calcium and taking calcitriol. The Pearson correlation analysis showed that hypothyroidism in patients with MHD was associated with patient age, diabetes mellitus, serum calcium level, serum phosphorus level and plasma albumin level. Logistic regression analysis showed that the age of MHD patients and the serum levels of phosphorus were independent risk factors for hypoparathyroidism. Conclusion MHD patients prone to low parathyroid hormone levels, age and the level of serum phosphorus was the independent risk factors for low parathyroid hormone levels in MHD patients
出处 《宁夏医学杂志》 CAS 2017年第12期1089-1092,共4页 Ningxia Medical Journal
关键词 低甲状旁腺激素 维持性血液透析 影响因素 Parathyroid hormone Maintenance hemodialysis Influencing factors
  • 相关文献

参考文献4

二级参考文献25

  • 1孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:63
  • 2Kimata N, Albert JM, Akiba T, et al. Association of mineral metabolism factors with all cause and cardiovascular mor tality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study[J].Hemodial Int, 2007, 11:340-348.
  • 3Wald R, Tentori F, Tighiouart H, et al. Impact of the Kidney Disease outcomes Quality Initiative(KDOQI)Clinical practice Guidelines for Bone Metabolism and Disease in a large dialysis network[J].Am I Kidney Dis, 2007,49:257 266.
  • 4Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)[J].Am J Kidney Dis, 2008, 52:519- 530.
  • 5Mendelssohn DC, Pisoni RL, hrrington CJ, et al.A practice- related risk score (PRS): A DOPPS-derived aggregate qual ity index for haemodialysis facilities[J].Nephrol Dial Transplant, 2008,23:3227-3233.
  • 6王海燕,王梅主译.慢性肾脏病及透析的临床实践指南[M].北京人民卫生出版社,2003,89.
  • 7Block GA, Klassen PS, LazarusJM, et al. Mineralmetabolism, mortality, and morbidity in maintenance hemodialysis[J]. J Am Soc Nephrol,2004,15:2208 2218.
  • 8Chertow GM, Raggi P, Chasan Tabar S, et al. Determinants of progressive vascular calcification in hemodia]ysis patients [J]. Nephrol Dial Transplant, 2004,19:1489-1496.
  • 9~ang H, Curinga G, Giachelli CM. Elevated extracellular cal cium levels induce smooth muscle cell matrix mineraliza tion in vitro[J]. Kidney Int, 2004,66:2293-2299.
  • 10Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guide- line for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) [J]. Kidney Int, 2009, 76 (Suppl 113): S1-S130.

共引文献142

同被引文献16

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部